Thiomaltol-Based Organometallic Complexes with 1-Methylimidazole as Leaving Group: Synthesis, Stability, and Biological Behavior

The development of RAPTA compounds for the treatment of tumors

(2016) Benjamin S. Murray et al.   COORDINATION CHEMISTRY REVIEWS

Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines

(2016) Lea S. Flocke et al.   INVESTIGATIONAL NEW DRUGS

Approaches to the design of catalytic metallodrugs

(2015) Joan J Soldevila-Barreda et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential

(2015) P.-S. Kuhn et al.   DALTON TRANSACTIONS

Solution equilibria and antitumor activities of pentamethylcyclopentadienyl rhodium complexes of picolinic acid and deferiprone

(2015) Éva A. Enyedy et al.   JOURNAL OF COORDINATION CHEMISTRY

Comparative solution equilibrium studies on pentamethylcyclopentadienyl rhodium complexes of 2,2ʹ-bipyridine and ethylenediamine and their interaction with human serum albumin

(2015) Éva A. Enyedy et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

1,3-Dioxoindan-2-carboxamides as Bioactive Ligand Scaffolds for the Development of Novel Organometallic Anticancer Drugs

(2015) Stephan Mokesch et al.   ORGANOMETALLICS

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

(2014) Suzanne Leijen et al.   INVESTIGATIONAL NEW DRUGS

Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: Synthesis, solution speciation and bioactivity

(2014) Orsolya Dömötör et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Microwave-assisted synthesis of N-heterocycle-based organometallics

(2014) Melanie Schmidlehner et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo

(2013) Petra Heffeter et al.   EUROPEAN JOURNAL OF CANCER

Bulky N(,N)-(Di)alkylethane-1,2-diamineplatinum(II) Compounds as Precursors for Generating Unsymmetrically Substituted Platinum(IV) Complexes

(2013) Verena Pichler et al.   INORGANIC CHEMISTRY

Solution equilibria of anticancer ruthenium(II)-(η6-p-cymene)-hydroxy(thio)pyr(id)one complexes: Impact of sulfur vs. oxygen donor systems on the speciation and bioactivity

(2013) Éva A. Enyedy et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Mono-carboxylated diaminedichloridoplatinum(iv) complexes – selective synthesis, characterization, and cytotoxicity

(2011) Verena Pichler et al.   DALTON TRANSACTIONS

ShelXle: a Qt graphical user interface forSHELXL

(2011) Christian B. Hübschle et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY

Biomolecule binding vs. anticancer activity: Reactions of Ru(arene)[(thio)pyr-(id)one] compounds with amino acids and proteins

(2011) Samuel M. Meier et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Is the Reactivity of M(II)−Arene Complexes of 3-Hydroxy-2(1H)-pyridones to Biomolecules the Anticancer Activity Determining Parameter?

(2010) Muhammad Hanif et al.   INORGANIC CHEMISTRY

Organometallic ruthenium-based antitumor compounds with novel modes of action

(2010) Wee Han Ang et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Maltol-Derived Ruthenium-Cymene Complexes with Tumor Inhibiting Properties: The Impact of Ligand-Metal Bond Stability on Anticancer Activity In Vitro

(2009) Wolfgang Kandioller et al.   CHEMISTRY-A EUROPEAN JOURNAL

OLEX2: a complete structure solution, refinement and analysis program

(2009) Oleg V. Dolomanov et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY

From Pyrone to Thiopyrone Ligands−Rendering Maltol-Derived Ruthenium(II)−Arene Complexes That Are Anticancer Active in Vitro

(2009) Wolfgang Kandioller et al.   ORGANOMETALLICS

Resistance against novel anticancer metal compounds: Differences and similarities

(2008) P HEFFETER et al.   DRUG RESISTANCE UPDATES

Water-soluble arene ruthenium complexes containing pyridinethiolato ligands: Synthesis, molecular structure, redox properties and anticancer activity of the cations [(η6-arene)Ru(p-SC5H4NH)3]2+

(2008) Michaël Gras et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

Catalytic organometallic anticancer complexes

(2008) S. J. Dougan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA